Extracorporeal lung perfusion

Current Opinion in Organ Transplantation

Volumn 16, Issue 5, 2011, Pages 469-475

  Cypel, Marcelo ^a   Keshavjee, Shaf ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Ex vivo lung perfusion; lung injury; lung preservation; lung repair

Indexed keywords

ACTIVATED PROTEIN C; ALPHA 1 ANTITRYPSIN; ANTIBIOTIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; I KAPPA B; INTERLEUKIN 10; SMALL INTERFERING RNA; UROKINASE;

ACID ASPIRATION; ARTIFICIAL VENTILATION; BODY TEMPERATURE; EX VIVO LUNG PERFUSION; GENE THERAPY; HUMAN; LUNG EDEMA; LUNG EMBOLISM; LUNG FUNCTION; LUNG PERFUSION; LUNG TRANSPLANTATION; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; ORGAN DONOR; ORGAN PRESERVATION; PATIENT SELECTION; PNEUMONIA; PRIMARY GRAFT DYSFUNCTION; REVIEW;

EXTRACORPOREAL MEMBRANE OXYGENATION; HUMANS; LUNG TRANSPLANTATION; PERFUSION; PREOPERATIVE CARE; TISSUE AND ORGAN PROCUREMENT;

EID: 80052688840     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e32834ab15a     Document Type: Review

References (54)

1. Punch JD, Hayes DH, LaPorte FB, et al. Organ donation and utilization in the United States, 1996-2005. Am J Transplant 2007; 7 (5 Pt 2):1327-1338. (Pubitemid 46606938)
2. De Meester J, Smits J, Persijn G, Haverich A. Listing for lung transplantation: life expectancy and transplant effect, stratified by type of end-stage lung disease, the Eurotransplant experience. J Heart Lung Transplant 2001; 20:518-524. (Pubitemid 32410013)
3. Lederer DJ, Arcasoy SM, Wilt JS, et al. Six-minute-walk distance predicts waiting list survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2006; 174:659-664. (Pubitemid 44395333)
4. Hopkinson DN, Bhabra MS, Hooper TL. Pulmonary graft preservation: a worldwide survey of current clinical practice. J Heart Lung Transplant 1998; 17:525-531. (Pubitemid 28247039)
5. Fischer S, Matte-Martyn A, De Perrot M, et al. Low-potassium dextran preservation solution improves lung function after human lung transplantation. J Thorac Cardiovasc Surg 2001; 121:594-596. (Pubitemid 32230234)
6. Southard JH, Belzer FO. Organ preservation. Annu Rev Med 1995; 46:235.
7. Muller C, Hoffmann H, Bittmann I, et al. Hypothermic storage alone in lung preservation for transplantation: a metabolic, light microscopic, and functional analysis after 18 h of preservation. Transplantation 1997; 63:625-630. (Pubitemid 27132190)
8. Pegg DE. Organ preservation. Surg Clin N Am 1986; 66:617-632. (Pubitemid 16057682)
9. Carrel A, Lindbergh CA. The culture of whole organs. Science 1935; 81:621-623.
10. Brasile L, Stubenitsky BM, Booster MH, et al. Overcoming severe renal ischemia: the role of ex vivo warm perfusion. Transplantation 2002; 73:897-901. (Pubitemid 34252351)
11. Brasile L, Stubenitsky BM, Haisch CE, et al. Repair of damaged organs in vitro. Am J Transplant 2005; 5:300-306. (Pubitemid 40179516)
12. Vogel T, Brockmann JG, Friend PJ. Ex-vivo normothermic liver perfusion: an update. Curr Opin Organ Transplant 2010; 15:167-172.
13. Steen S, Liao Q, Wierup PN, et al. Transplantation of lungs from nonheartbeating donors after functional assessment ex vivo. Ann Thorac Surg 2003; 76:244-252. (Pubitemid 36819750)
14. Daemen JW, Kootstra G, Wijnen RM, et al. Nonheart-beating donors: the Maastricht experience. Clin Transpl 1994:303-316.
15. Steen S, Sjoberg T, Pierre L, et al. Transplantation of lungs from a nonheartbeating donor. Lancet 2001; 357:825-829.
16. Aitchinson JD, Orr HE, Flecknell PA, et al. Functional assessment of nonheartbeating donor lungs: prediction of posttransplant function. Eur J Cardiothorac Surg 2001; 20:187-194. (Pubitemid 32567589)
17. Rega FR, Vanaudenaerde BM, Wuyts WA, et al. IL-1beta in bronchial lavage fluid is a noninvasive marker that predicts the viability of the pulmonary graft from the nonheart-beating donor. J Heart Lung Transplant 2003; 24:20-28. (Pubitemid 40093987)
18. Rega FR, Jannis NC, Verleden GM, et al. Long-term preservation with interim evaluation of lungs from a nonheart-beating donor after a warm ischemic interval of 90 min. Ann Surg 2003; 238:782-792.
19. Neyrinck AP, Van De Wauewer C, Geudens N, et al. Wouters comparative study of donor lung injury in heart-beating versus nonheart-beating donors. Eur J Cardiothorac Surg 2006; 30:628-636. (Pubitemid 44332938)
20. Egan TM, Haitchcock JA, Nicotra WA, et al. Ex vivo evaluation of human lungs for transplant suitability. Ann Thorac Surg 2006; 81:1205-1213.
21. Snell GI, Oto T, Levvey B, et al. Evaluation of techniques for lung transplantation following donation after cardiac death. Ann Thorac Surg 2006; 81:2014-2019. (Pubitemid 43775541)
22. Wierup P, Haraldsson A, Nilsson F, et al. Ex vivo evaluation of nonacceptable donor lungs. Ann Thorac Surg 2006; 81:460-466. (Pubitemid 43120535)
23. Erasmus ME, Fernhout MH, Elstrodt JM, Rakhorst G. Normothermic ex vivo lung perfusion of nonheart-beating donor lungs in pigs: from pretransplant function analysis towards a 6-h machine preservation. Transplant Int 2006; 19:589-593. (Pubitemid 43881759)
24. Cypel M, Yeung JC, Hirayama S, et al. Technique for prolonged normothermic ex vivo lung perfusion. J Heart Lung Transplant Dec 2008; 27:1319-1325.
25. Cypel M, Rubacha M, Yeung J, et al. Normothermic ex vivo perfusion prevents lung injury compared to extended cold preservation for transplantation. Am J Transplant 2009; 9:2262-2269.
26. Cypel M, Yeung JC, Liu M, et al. Normothermic ex vivo lung perfusion in clinical lung transplantation. N Engl J Med 2011; 364:1431-1440.
27. Steen S, Sjoberg T, Pierre L, et al. Transplantation of lungs from a nonheartbeating donor. Lancet 2001; 357:825-829.
28. Ingemansson R, Eyjolfsson A, Mared L, et al. Clinical transplantation of initially rejected donor lungs after reconditioning ex vivo. Ann Thorac Surg 2009; 87:255-260.
29. Lindstedt S, Hlebowicz J, Koul B, et al. Comparative outcome of double lung transplantation using conventional donor lungs and nonacceptable donor lungs reconditioned ex vivo. Interact Cardiovasc Thorac Surg 2011; 12:162-165.
30. Frank JA, Briot R, Lee JW, et al. Physiological and biochemical markers of alveolar epithelial barrier dysfunction in perfused human lungs. Am J Physiol Lung Cell Mol Physiol 2007; 293:52-59.
31. Sakuma T, Gu X, Wang Z, et al. Stimulation of alveolar epithelial fluid clearance in human lungs by exogenous epinephrine. Crit Care Med 2006; 34:676-681.
32. Frank JA, Briot R, Lee JW, et al. Physiological and biochemical markers of alveolar epithelial barrier dysfunction in perfused human lungs. Am J Physiol Lung Cell Mol Physiol 2007; 293:L52-L59. (Pubitemid 47080706)
33. Planes C, Blot-Chabaud M, Matthay MA, et al. Hypoxia and beta 2-agonists regulate cell surface expression of the epithelial sodium channel in native alveolar epithelial cells. J Biol Chem 2002; 277:47318-47324. (Pubitemid 36159245)
34. Ware LB, Wang Y, Fang X, et al. Assessment of lungs rejected for transplantation and implications for donor selection. Lancet 2002; 360:619-620. (Pubitemid 35232198)
35. Oto T, Excell L, Griffiths AP, et al. The implications of pulmonary embolism in a multiorgan donor for subsequent pulmonary, renal, and cardiac transplantation. J Heart Lung Transplant 2008; 27:78-85.
36. Inci I, Zhai W, Arni S, et al. Fibrinolytic treatment improves the quality of lungs retrieved from nonheart-beating donors. J Heart Lung Transplant 2007; 26:1054-1060. (Pubitemid 47494662)
37. Inci I, Ampollini L, Arni S, et al. Ex vivo reconditioning of marginal donor lungs injured by acid aspiration. J Heart Lung Transplant 2008; 27:1229-1236.
38. Karamanou DM, Perry J, Walden HR, et al. The effect of ex-vivo perfusion on the microbiological profile of the donor lung. J Heart Lung Transplant 2010 (Suppl 2):S88.
39. de Perrot M, Liu M, Waddell T, Keshavjee S. Ischemia-reperfusion-induced lung injury. Am J Respir Cell Mol Biol 2003; 28:616-625.
40. Kaneda H, Waddell TK, de Perrot M, et al. Preimplantation multiple cytokine mRNA expression analysis of donor lung grafts predicts survival after lung transplantation in humans. Am J Transplant 2006; 6:544-551. (Pubitemid 43382141)
41. Fisher AJ, Donnelly SC, Hirani N, et al. Elevated levels of interleukin-8 in donor lungs is associated with early graft failure after lung transplantation. Am J Respir Crit Care Med 2001; 163:259-265. (Pubitemid 32095278)
42. Hirayama S, Cypel M, Sato M, et al. Activated protein C in ischemia-reperfusion injury after experimental lung transplantation. J Heart Lung Transplant 2009; 28:1180-1184.
43. Nita I, Hollander C, Westin U, Janciauskiene SM. Prolastin, a pharmaceutical preparation of purified human alpha1-antitrypsin, blocks endotoxin-mediated cytokine release. Respir Res 2005; 6:12.
44. Ishiyama T, Dharmarajan S, Hayama M, et al. Inhibition of nuclear factor kappaB by IkappaB superrepressor gene transfer ameliorates ischemiareperfusion injury after experimental lung transplantation. J Thorac Cardiovasc Surg 2005; 130:194-201. (Pubitemid 40941690)
45. Fischer S, Liu M,MacLean AA, et al. In vivo transtracheal adenovirus-mediated transfer of human interleukin-10 gene to donor lungs ameliorates ischemiareperfusion injury and improves early posttransplant graft function in the rat. Hum gene Ther 2001; 12:1513-1526. (Pubitemid 34248287)
46. Martins S, de Perrot M, Imai Y, et al. Transbronchial administration of adenoviral-mediated interleukin-10 gene to the donor improves function in a pig lung transplant model. Gene Ther 2004; 11:1786-1796. (Pubitemid 40028540)
47. Cypel M, Liu M, Rubacha M, et al. Functional repair of human donor lungs by IL-10 gene therapy. Sci Transl Med 2009; 1:1-9.
48. Ritter T, Kupiec-Weglinski JW. Gene therapy for the prevention of ischemia/reperfusion injury in organ transplantation. Curr Gene Ther 2005; 5:101-109. (Pubitemid 40246743)
49. Cassivi SD, Cardella JA, Fischer S, et al. Transtracheal gene transfection of donor lungs prior to organ procurement increases transgene levels at reperfusion and following transplantation. J Heart Lung Transplant 1999; 18:1181-1188.
50. Chapelier A, Danel C, Mazmanian M, et al. Gene therapy in lung transplantation: feasibility of ex vivo adenovirus-mediated gene transfer to the graft. Hum Gene Ther 1996; 7:1837-1845. (Pubitemid 26364592)
51. Pellegrini C, O'Brien T, Jeppsson A, et al. Influence of temperature on adenovirus-mediated gene transfer. Eur J Cardiothorac Surg 1998; 13:599-603. (Pubitemid 28273355)
52. Yeung JC, Wagnetz D, Koike T, et al. Ex vivo adenoviral vector gene delivery results in decreased vector-associated inflammation pre and post lung transplantation. J Heart Lung Transplant 2010; 29 (Suppl 2):S95.
53. Lee JW, Fang X,Gupta N, et al. Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung. Proc Natl Acad Sci USA 2009; 106:16357-16362.
54. Brasile L, Glowacki P, Castracane J, Stubenitsky BM. Pretransplant kidneyspecific treatment to eliminate the need for systemic immunosuppression. Transplantation 2010; 90:1294-1298.